ETX101 shows promising early signals in Dravet syndrome on November 02, 2026 ETX101 gene therapy Infantile Severe Myoclonic Epilepsy neurodevelopment POLARIS SCN1A gene Seizures +
Sanofi rules out major restructuring as it prepares for Dupixent’s patent loss on November 02, 2026 Dupixent M&A patent cliff R&D restructuring sanofi +
FDA approves camizestrant combination for ESR1-mutated advanced breast cancer on November 02, 2026 Accelerated Approval camizestrant CDK4/6 inhibitor ESR1 gene Etcamah HR-positive/HER2-negative breast cancer Mutation SERENA-6 United States Food and Drug Administration +
Recent Alzheimer’s developments across France, Germany, Italy and Spain on November 02, 2026 Care capacity Diagnosis Donanemab France Germany Italy Lecanemab Policy Presenile dementia Reimbursement Spain Technology Assessment, Biomedical +